Author

Hye-Jung Kim

Harvard UniversityORCID 0009-0001-3519-4541Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Ashwin Srinivasan KumariD· 1 shared Dai FukumuraiD· 1 shared Dan Gabriel DudaiD· 1 shared David H. EbbiD· 1 shared Landry BlanciD· 1 shared Lei XuiD· 1 shared Mark A. Duquette· 1 shared Meenal DattaiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Ashwin Srinivasan KumarORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintAug 14, 2026

Targeting Tumor-derived Sphingosine Kinase 2 Unleashes Antitumor Immunity and Improves Survival of Mice with Group 3 Medulloblastoma

Sampurna Chatterjee, Pragya Kumar, Ashwin Srinivasan Kumar…·Rakesh K. Jain

This study identifies SPHK2 as a therapeutic target in G3MB, showing that its inhibition restores anti-tumor immunity and improves survival in mouse models, with enhanced effects when combined with radiation.

DOI 10.64898/2026.08.12.744521

mouseexperimental assay

𝕏 PostBluesky